Status:
COMPLETED
Growth Hormone Treatment of Women With Turner Syndrome
Lead Sponsor:
Britta E. Hjerrild
Conditions:
Turner Syndrome
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
Growth hormone treatment is used in girls with Turner syndrome to increase final height. The aim of this study is to evaluate the effect of growth hormone treatment on body composition and heart funct...
Detailed Description
This study is a randomised, double-blinded, controlled clinical trial to evaluate the effect of growth hormone (GH) treatment on adult women with Turner syndrome. The endpoints will be changes in body...
Eligibility Criteria
Inclusion
- Turner syndrome
- Age 20-40
Exclusion
- Symptomatic heart disease
- Anti hypertensive treatment
- Untreated thyroid disease
- Adipositas (BMI \> 35)
- Treatment with glucocorticoids
- Pregnancy
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00420654
Start Date
August 1 2007
End Date
September 1 2011
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital
Aarhus, DK, Denmark, 8000